Home/Velvio/Prof. Dr. med Ulrich Bogdahn
PD

Prof. Dr. med Ulrich Bogdahn

Chief Medical Officer

Velvio

Velvio Pipeline

DrugIndicationPhase
NVP-13Amyotrophic Lateral Sclerosis (ALS)Pre-clinical
Immune-Oncology ProgramsSolid TumorsResearch
Liver Disease ProgramsLiver Disease (e.g., fibrosis)Research